Plasma Cell Dysacrasias Flashcards
Waldenstrom’s macrogammaglobulinemia phenotype
- mature B cell
symptoms of smoldering multiple myeloma
- asymptomatic
light chains in amyloidosis
- lambda light chains
result of malignant plasma cells interacting with bone marrow microenvironment
- activation of osteoclasts - suppression of osteoblasts - leads to lytic bone disease
amyloidosis present with which stain?
- congo red staining of bone marrow biopsy
immunoglobulins most often found in MM
- IgG - IgA - light chains only
risk of developing myeloma from MGUS
- 1% per year
case symptoms of Waldenstrom’s macrogammaglobulinemia
- headache - blurred vision - hyperviscosity
Waldenstrom’s macrogammaglobulinemia most symptoms caused by
- elevated IgM
gender most impacted by multiple myeloma
- males
bence jones protein
- kappa light chains in urine protein electrophoresis
Waldenstrom’s macrogammaglobulinemia associated with which immunoglobulin
- IgM
risk factors for multiple myeloma
- age - gender - race - family history - radiation exposure - chronic antigenic stimulation
which population is impacted by PCD
- adults
diagnosis test for Waldenstrom’s macrogammaglobulinemia
- SPEP showing IgM monoclonal spike - serum viscosity
race most impacted by multiple myeloma
- African Americans
risk of developing myeloma from smoldering
- 10% per year
Waldenstrom’s macrogammaglobulinemia is a disease of which population
- adults
PCD are diseases associated with
- monoclonal proliferation of immunoglobulin producing plasma cells
precursor protein in amyloidosis
- secreted in a soluble state - becomes insoluble at some tissue sites and compromises organ function
Waldenstrom’s macrogammaglobulinemia related to cancer?
- low grade lymphoma - involving bone marrow and spleen
smoldering myeloma labs
- > 3.0 g/dL serum monoclonal protein OR > 10-60% bone marrow plasma cells OR - urinary monoclonal protein AND - no myeloma defining events
Amyloid light chain amyloidosis associated with
- multiple myeloma - abnormal light chains
lab values for MGUS
- < 3.0 g/dL serum monoclonal protein AND - < 10% monoclonal plasma cells in bone marrow - no end organ damage